Literature DB >> 20696825

Effect of Borrelia burgdorferi OspC at the site of inoculation in mouse skin.

Styliani Antonara1, Laura Ristow, James McCarthy, Jenifer Coburn.   

Abstract

The Borrelia burgdorferi surface lipoprotein OspC is a critical virulence factor, but its precise role in the establishment of B. burgdorferi infection remains unclear. To determine whether OspC affects the host response at the site of inoculation of the bacterium, the recruitment of macrophages and neutrophils and the production of cytokines were examined at the site of infection by wild-type, ospC mutant, and complemented mutant B. burgdorferi strains. Of the 21 cytokines tested, monocyte chemoattractant protein 1 (MCP-1), keratinocyte-derived chemokine (KC, CXCL1), and vascular endothelial growth factor (VEGF) were found at increased levels at the site of inoculation of B. burgdorferi, and the levels varied with the production of OspC at one or more time points over the 1-week course of infection. The kinetics of expression and the dependence on OspC production by B. burgdorferi varied among the cytokines. The production of KC and MCP-1, and the appearance of monocytic infiltrates, correlated with the presence of the bacteria rather than with OspC specifically. In contrast, VEGF production was not correlated simply to the presence of the bacteria and is influenced by the presence of OspC. In in vitro assays, OspC and B. burgdorferi expressing OspC stimulated the growth of endothelial cells more than did the controls. These data suggest the possibility of a novel role for OspC in the life of B. burgdorferi at the interface of its mammalian and tick hosts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696825      PMCID: PMC2976318          DOI: 10.1128/IAI.00464-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens.

Authors:  Marissa H Braff; Mohamed Zaiou; Joshua Fierer; Victor Nizet; Richard L Gallo
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Analysis of the ospC regulatory element controlled by the RpoN-RpoS regulatory pathway in Borrelia burgdorferi.

Authors:  Xiaofeng F Yang; Meghan C Lybecker; Utpal Pal; Sophie M Alani; Jon Blevins; Andrew T Revel; D Scott Samuels; Michael V Norgard
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

3.  Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1.

Authors:  Aruna K Behera; Ethan Hildebrand; Satoshi Uematsu; Shizuo Akira; Jenifer Coburn; Linden T Hu
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Increasing the recruitment of neutrophils to the site of infection dramatically attenuates Borrelia burgdorferi infectivity.

Authors:  Qilong Xu; Sunita V Seemanapalli; Kathryn E Reif; Charles R Brown; Fang Ting Liang
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

5.  Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity.

Authors:  Qilong Xu; Sunita V Seemanapalli; Kristy McShan; Fang Ting Liang
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

6.  Delineating the requirement for the Borrelia burgdorferi virulence factor OspC in the mammalian host.

Authors:  Philip E Stewart; Xiaohui Wang; Dawn M Bueschel; Dawn R Clifton; Dorothee Grimm; Kit Tilly; James A Carroll; Janis J Weis; Patricia A Rosa
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection.

Authors:  Kit Tilly; Jonathan G Krum; Aaron Bestor; Mollie W Jewett; Dorothee Grimm; Dawn Bueschel; Rebecca Byram; David Dorward; Mark J Vanraden; Philip Stewart; Patricia Rosa
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

8.  Rapid clearance of Lyme disease spirochetes lacking OspC from skin.

Authors:  Kit Tilly; Aaron Bestor; Mollie W Jewett; Patricia Rosa
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

9.  Short report: Association of macrophage inflammatory response and cell death after in vitro Borrelia burgdorferi infection with arthritis resistance.

Authors:  Lisa J Glickstein; Jenifer L Coburn
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

10.  Temperature-induced regulation of RpoS by a small RNA in Borrelia burgdorferi.

Authors:  Meghan C Lybecker; D Scott Samuels
Journal:  Mol Microbiol       Date:  2007-05       Impact factor: 3.501

View more
  15 in total

1.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

2.  The Borrelia burgdorferi integrin ligand P66 affects gene expression by human cells in culture.

Authors:  Michelle E LaFrance; Jessica V Pierce; Syliani Antonara; Jenifer Coburn
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

3.  Outer surface protein OspC is an antiphagocytic factor that protects Borrelia burgdorferi from phagocytosis by macrophages.

Authors:  Sebastian E Carrasco; Bryan Troxell; Youyun Yang; Stephanie L Brandt; Hongxia Li; George E Sandusky; Keith W Condon; C Henrique Serezani; X Frank Yang
Journal:  Infect Immun       Date:  2015-10-05       Impact factor: 3.441

4.  Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-binding protein BBK32 is required for optimal infectivity.

Authors:  Jenny A Hyde; Eric H Weening; Mihee Chang; Jerome P Trzeciakowski; Magnus Höök; Jeffrey D Cirillo; Jon T Skare
Journal:  Mol Microbiol       Date:  2011-08-30       Impact factor: 3.501

5.  The β₃-integrin ligand of Borrelia burgdorferi is critical for infection of mice but not ticks.

Authors:  Laura C Ristow; Halli E Miller; Lavinia J Padmore; Rekha Chettri; Nita Salzman; Melissa J Caimano; Patricia A Rosa; Jenifer Coburn
Journal:  Mol Microbiol       Date:  2012-07-18       Impact factor: 3.501

6.  Pervasive recombination and sympatric genome diversification driven by frequency-dependent selection in Borrelia burgdorferi, the Lyme disease bacterium.

Authors:  James Haven; Levy C Vargas; Emmanuel F Mongodin; Vincent Xue; Yozen Hernandez; Pedro Pagan; Claire M Fraser-Liggett; Steven E Schutzer; Benjamin J Luft; Sherwood R Casjens; Wei-Gang Qiu
Journal:  Genetics       Date:  2011-09-02       Impact factor: 4.562

7.  Changes in bacterial growth rate govern expression of the Borrelia burgdorferi OspC and Erp infection-associated surface proteins.

Authors:  Brandon L Jutras; Alicia M Chenail; Brian Stevenson
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

8.  Characterization of Stress and Innate Immunity Resistance of Wild-Type and Δp66 Borrelia burgdorferi.

Authors:  Michael W Curtis; Beth L Hahn; Kai Zhang; Chunhao Li; Richard T Robinson; Jenifer Coburn
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

9.  Microarray analyses of inflammation response of human dermal fibroblasts to different strains of Borrelia burgdorferi sensu stricto.

Authors:  Frédéric Schramm; Aurélie Kern; Cathy Barthel; Sophie Nadaud; Nicolas Meyer; Benoît Jaulhac; Nathalie Boulanger
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Heterogeneity of Borrelia burgdorferi Sensu Stricto Population and Its Involvement in Borrelia Pathogenicity: Study on Murine Model with Specific Emphasis on the Skin Interface.

Authors:  Aurélie Kern; Gilles Schnell; Quentin Bernard; Amandine Bœuf; Benoît Jaulhac; Elody Collin; Cathy Barthel; Laurence Ehret-Sabatier; Nathalie Boulanger
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.